TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Cogent Biosciences
Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting

Cogent Biosciences will present data on bezuclastinib for NonAdvanced Systemic Mastocytosis at the ASH annual meeting, highlighting potential disease modification and introducing a new JAK2 V617F mutant-selective inhibitor program.

Insights
GPN   neutral

Mentioned in context of CFO Paul Todd's previous role


COGT   positive

Company is showcasing promising clinical trial results, announcing new research programs, and expressing confidence in potential breakthrough therapies for systemic mastocytosis and other genetically defined diseases